Testosterone Improves Sexual Function in Postmenopausal Women

December 2008
Maedica - a Journal of Clinical Medicine;2008, Vol. 3 Issue 4, p305
Academic Journal
The article focuses on the use of testosterone for improving sexual function in postmenopausal women. It is stated that hypoactive sexual desire disorder is commonly found among postmenopausal women. Several studies have shown that there has been a significant increase in libido after using transdermal patch delivering 300 μg of testosterone per day in women in combination with a estrogen replacement therapy. In a study, it was found that breast cancer was diagnosed in 4 women who received testosterone. It is stated that administration of testosterone in postmenopausal women not receiving estrogen therapy significantly improves their sexual function, but the long-term effects of testosterone have not yet been found.


Related Articles

  • Testosterone for the Treatment of Hypoactive Sexual Desire Disorder: Part II. Feldhaus-Dahir, Melissa // Urologic Nursing;Sep/Oct2009, Vol. 29 Issue 5, p386 

    The article discusses the use of testosterone in the clinical management of hypoactive sexual desire disorder (HSDD) in women. A historical perspective on testosterone is presented, including the approval of the U.S. Food and Drug Administration (FDA) for its clinical applications. The link...

  • Beyond Hormones. Ringel, Marcia // Patient Care;4/30/1998, Vol. 32 Issue 8, p28 

    Discusses several alternate treatments for menopausal symptoms. In-depth look at estrogen replacement therapy; Fear by postmenopausal women that estrogen is linked to breast cancer; Details on hormone replacement therapy. INSETS: Phytoestrogens on the menu;Behavioral solutions for hot flashes...

  • Women's Health Update. Hudson, Tori // Townsend Letter for Doctors & Patients;Oct2003, Issue 243, p173 

    Discusses issues concerning the health of women as of October 2003 in the U.S. Effect of estrogen plus progestin on stroke; Guidelines for the detection of breast cancer; Impact of hormone replacement therapy on menopausal symptoms.

  • Estrogen Use and Postmenopausal Women: A National Institutes of Health Consensus Development Conference.  // Annals of Internal Medicine;Dec79, Vol. 91 Issue 6, p921 

    Focuses on studies presented at the 1979 National Institutes of Health conference regarding the risks and benefits of estrogen use among postmenopausal women. Effectiveness of estrogens; Evidence for adverse effect of menopausal estrogens; Association of estrogens and breast cancer.

  • Consensus statement for non-estrogen-based treatments for menopausal symptoms. Woyka, Jane; Tanna, Nuttan // Post Reproductive Health;Jun2014, Vol. 20 Issue 2, p76 

    Non-estrogen-based therapies can be used for the treatment of hot flushes, for symptoms of urogenital atrophy and for lack of sexual desire and/or fatigue not improved by estrogen treatments. Treatment choice should be based on up-to-date information and targeted to individual women’s...

  • Estrogens, androgens can help during menopause. Charters, Lynda // Urology Times;Apr99, Vol. 27 Issue 4, p32 

    Reports that various estrogen and androgen forms can treat physiologic and emotional problems brought on by menopause. Decline of hormone levels and reduced vaginal blood flow; Side effects of treatment.

  • Dealing With the Hormone Dilemma. Hannon, Kerry // U.S. News & World Report;Feb2010, Vol. 147 Issue 2, p51 

    This article describes hormone therapy to ease menopausal symptoms. The case of Susan Kirchoff is cited as an example of the proper way to approach hormone therapy. Kirchoff was concerned about the side effects of such therapy because of her family history of breast cancer and her own high...

  • Testosterone patch for female low libido.  // Pulse;1/5/2004, Vol. 64 Issue 1, p36 

    Answers a question on the use of testosterone patches for women with low libido. Degree of effectiveness of the patches.

  • Timing of follow-up densitometry in hormone replacement therapy users for optimal osteoporosis prevention. Checa, Miguel A.; Rio, L. Del; Rosales, J.; Nogués, X.; Vila, J.; Carreras, R. // Osteoporosis International;Aug2005, Vol. 16 Issue 8, p937 

    The objectives of the study were (1) to determine the time interval for repeat dual-energy X-ray absorptiometry (DXA) to detect significant bone loss, i.e., greater than the coefficient of variation (CV) of the center (2.8 × CV%) and (2) to assess how long hormone replacement therapy can be...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics